EyePoint (EYPT) Change in Inventory (2018 - 2026)
EyePoint (EYPT) posted Change in Inventory of -$563000.0 for Q1 2026, down 89.56% sequentially from -$297000.0 in Q4 2025, and down 219.89% YoY from $469611.4 in Q1 2025.
EyePoint (EYPT) Change in Inventory (2018 - 2026) Analysis & Trends
EyePoint has reported Change in Inventory for 9 years, with the latest figure at -$563000.0 in Q1 2026.
- Quarterly Change in Inventory fell 219.89% year-over-year to -$563000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$879000.0 (up 58.67% YoY) and the FY2025 annual result came in at -$492000.0, up 69.25% from the prior year.
- Change in Inventory retreated to -$563000.0 in Q1 2026 per EYPT's latest filing, from -$297000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $1.2 million in Q1 2023 and troughed at -$865000.0 in Q3 2024.
- A 5-year average of -$20117.6 and a median of -$176000.0 in 2025 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 982.93% in 2023, then slumped 374.6% in 2024.
- Over 5 years, Change in Inventory stood at $845000.0 in 2022, then plunged by 179.41% to -$671000.0 in 2023, then climbed by 25.19% to -$502000.0 in 2024, then jumped by 40.84% to -$297000.0 in 2025, then plunged by 89.56% to -$563000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$563000.0, -$297000.0, and -$568000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 632,000.00 |
| Jun 30, 2026 | 632,000.00 |
| Mar 31, 2026 | -563,000.00 |
| Mar 31, 2026 | -563,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Sep 30, 2025 | -568,000.00 |
| Sep 30, 2025 | -568,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Jun 30, 2025 | 549,000.00 |
| Mar 31, 2025 | -176,000.00 |
| Mar 31, 2025 | -176,000.00 |
| Dec 31, 2024 | -502,000.00 |
| Dec 31, 2024 | -502,000.00 |
| Sep 30, 2024 | -865,000.00 |
| Sep 30, 2024 | -865,000.00 |
| Jun 30, 2024 | -584,000.00 |
| Jun 30, 2024 | -584,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Mar 31, 2024 | 351,000.00 |